Contract 75H71025F80116
Roche Diabetes Care Inc · Department Of Health And Human Services · February 9, 2026
Roche Diabetes Care Inc was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on February 9, 2026 for $142,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Indianapolis, IN. This is a task or delivery order issued under parent IDIQ V797D50597. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 10, 2026. If all options are exercised, the contract could reach $550,000.
Contract details
- PIID
- 75H71025F80116
- Parent IDIQ
- V797D50597
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Indianapolis, IN
- First action
- February 9, 2026
- Latest action
- February 10, 2026
Description
MOD 2 - ADD FUNDS - DIABETES CARE SUPPLIES FOR GALLUP INDIAN MEDICAL CENTER
Modification timeline
-
February 10, 2026Mod P00002 · Supplemental Agreement For Work Within Scope$244.0K
-
February 9, 2026Mod P00001 · Exercise An OptionMOD 1 - EXERCISE OPTION YEAR ONE - DIABETES CARE SUPPLIES$204.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71025F80116?
Contract 75H71025F80116 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Health And Human Services on February 9, 2026 for $142,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75H71025F80116?
Roche Diabetes Care Inc won contract 75H71025F80116 from Department Of Health And Human Services.
How much is contract 75H71025F80116 worth?
Contract 75H71025F80116 has obligated $142,000 to date, with a total potential value of $550,000 if all options are exercised.